Model
Edge
Moonlake Immunotherapeutics
0001920545
Filing Type
4
Filing Date
12/20/2023
Updated
12/21/23, 9:01 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership